Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients - Concepedia

Concepedia

Publication | Open Access

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

DOI Full Paper Access

219

Citations

24

References

2017

Year

Anthony R. Mato, Brian T. Hill, Nicole Lamanna, Paul M. Barr, Chaitra S. Ujjani, Danielle M. Brander, Cullan Howlett, Alan P Skarbnik, Bruce D. Cheson, Clive S. Zent,

Annals of Oncology

Hematological MalignancyLymphoid NeoplasiaOptimal SequencingChronic Lymphocytic LeukemiaMedicineMalignant Blood DisorderImmunologyHematologyPathologyMolecular DiagnosticsImmunotherapyOncologyMulticenter StudyCancer Research

References

	Year	Citations

Page 1

Page 1